CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ABBV

Venetoclax

Phase 3
AbbVie Inc. (ABBV)

Phase 3

Development Phase

8

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Nov '27
ABBVPhase 2

Venetoclax Phase 2 Est. Readout

Venetoclax
Nov 2027~
CT.gov
00%
Oct '27
ABBVPhase 2

Venetoclax Phase 2 Est. Readout

Venetoclax
Oct 2027~
CT.gov
00%
Q4 '27
ABBVPhase 2

Venetoclax Phase 2 Est. Readout

Venetoclax
Q4 2027~Q
CT.gov
00%
Aug '27
ABBVPhase 3

Venetoclax Phase 3 Est. Readout

Venetoclax
Aug 2027~
CT.gov
00%
Q3 '27
ABBVPhase 3

Venetoclax Phase 3 Est. Readout (MAJIC)

Venetoclax
Q3 2027~Q
CT.gov
00%
Jun '27
ABBVPhase 2

Venetoclax Phase 2 Est. Readout

Venetoclax
Jun 2027~
CT.gov
00%
Feb '27
ABBVPhase 2

Venetoclax Phase 2 Est. Readout

Venetoclax
Feb 2027~
CT.gov
00%
Dec '26
ABBVPhase 2

Venetoclax Phase 2 Est. Readout

Venetoclax
Dec 2026~
CT.gov
00%
Competitive Landscape

2 competitors in Acute Myeloid Leukemia (AML)

View Full Landscape
Drug Information

Target Indication

Acute Myeloid Leukemia (AML)

Clinical Trial

NCT03941964

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.